- Report of Foreign Issuer (6-K)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of November 2008

Commission File Number: 001-32186

YM BIOSCIENCES INC.

(Translation of registrant's name into English)

Suite 400, Building 11,

5045 Orbiter Drive

Mississauga, Ontario

Canada L4W 4Y4

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x

Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

Indicate by check mark whether by furnishing the information contained in this Form the registrant is also thereby furnishing

the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o

No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________

INCORPORATION BY REFERENCE

This Form 6-K is hereby incorporated by reference into the registration statements on Form S-8 (File No. 333-134410), Form F-10 (File No131250) and Form F-3 (File No. 120153) of YM BioSciences Inc.

DOCUMENTS FILED

See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	YM BIOSCIENCES INC.
	By:	/s/ Leonard Vernon
		Leonard Vernon Vice President, Finance and Administration

Date: November 3, 2008

EXHIBIT LIST

Exhibit		Description

99.1		News Release Dated November 3, 2008 - YM BIOSCIENCES REPORTS DATA FROM EXPLORATORY CLINICAL TRIALS OF NIMOTUZUMAB IN BRAIN METASTASES AND HIGH-GRADE GLIOMA PRESENTED AT 2008 EORTC-NCI-AACR ANNUAL MEETING